107 Armoring NKG2D CAR T cells with IL-18 improves in vivo anti-tumor activity
David Gilham,
Thủy Nguyễn,
Amélie Velghe,
Hannes Iserentant,
Eytan Breman,
Ann-Sophie Walravens,
Isabelle Gennart,
Benjamin Violle,
Fanny Huberty,
Nancy Ramelot,
Laure Twyffels,
Emilie Gauthy
Affiliations
David Gilham
Aff4 grid.462482.e0000000404170074Clinical and Experimental Immunotherapy Group, Institute of Cancer SciencesManchester Academic Healthcare Science Centre Manchester United Kingdom
Thủy Nguyễn
Celyad Oncology, Mont-Saint-Guibert, Belgium
Amélie Velghe
4 De Duve Institute, Université Catholique de Louvain, Brussels, Belgium
